IPO registrations (S-1, F-1) · Registrants
ARRAY BIOPHARMA INC
- SEC CIK
- 1100412 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2000-09-15, last 2000-11-16; 1 initial registration, 2 amendments
- Outcome
- Final prospectus filed 2000-11-17
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 3200 WALNUT STREET, Boulder, CO 80301
- EIN
- 84-1460811
- EDGAR entity type
- operating
- Insiders and CEO pay
- ARRAY BIOPHARMA INC on the corporate pages
Offering terms
- Proposed price range
- $8.00–$9.00 per share (S-1/A filed 2000-11-16)
- Final price
- $7.50 per share, below the range (424B4 filed 2000-11-17, an initial public offering)
- Shares sold
- 6,500,000
- Gross proceeds
- $48,750,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ARRY
- Lead underwriters
- Lehman Brothers (2,926,000 shares); Deutsche Bank (2,048,000 shares); Legg Mason (877,000 shares)
- Syndicate
- J.P. Morgan (65,000); ING Barings LLC (65,000); Prudential Securities (65,000); Cowen (65,000); UBS (65,000); Thomas Weisel Partners (65,000); Chatsworth Securities LLC (37,000); Dominick & Dominick LLC (37,000); Fahnestock & Co. Inc (37,000); Gerard Klauer Mattison & Co., Inc (37,000); Edward D. Jones & Co., L.P (37,000); PMG Capital (37,000); Raymond James (37,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ARRAY BIOPHARMA INC. EXACT (EIN (EXACT, as the state registration reports it))
- Business registration: Array BioPharma Inc. Fuzzy (name and state)
- Business registration: Array BioPharma Inc. Fuzzy (name and state)
- Business registration: ARRAY BIOPHARMA Inc. Fuzzy (name and state)
- Business registration: ARRAY BIOPHARMA INC. Fuzzy (name and state)
- Business registration: ARRAY BIOPHARMA INC. Fuzzy (name and state)
- Business registration: ARRAY BIOPHARMA INC. Fuzzy (name and state)
- Business registration: ARRAY BIOPHARMA INC. Fuzzy (name and state)
- Business registration: ARRAY BIOPHARMA INC. Fuzzy (name and state)
- Form 5500 plan sponsor: ARRAY BIOPHARMA INC. EXACT (EIN (EXACT))
- Federal award recipient: ARRAY BIOPHARMA INC Fuzzy (name and state)
- SEC filer: ARRAY BIOPHARMA INC EXACT (CIK (EXACT))
Filings 5
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-09-15 | S-1 | S-1 (registration) | ARRAY BIOPHARMA INC | 0001035704-00-000723 ↗ |
| 2000-10-27 | S-1/A | S-1/A (amendment) | ARRAY BIOPHARMA INC | 0001035704-00-000819 ↗ |
| 2000-11-16 | S-1/A | S-1/A (amendment) | ARRAY BIOPHARMA INC | 0001035704-00-000912 ↗ |
| 2000-11-17 | 424B4 | 424B4 (final prospectus) | ARRAY BIOPHARMA INC | 0001035704-00-000918 ↗ |
| 2002-02-13 | 424B4 | 424B4 (final prospectus) | ARRAY BIOPHARMA INC | 0001035704-02-000094 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2000-11-16 | S-1/A | registration statement | $8.00–$9.00 | 6,000,000 | - | Nasdaq ARRY | 3 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped, cover names 3 | document ↗ | |
| 2000-11-17 | 424B4 | final prospectus | $7.50 | 6,500,000 | $48,750,000 | Nasdaq ARRY | 16 | primary document; price sentence, shares headline, proceeds table, underwriting table 16, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| CARRUTHERS MICHAEL | Officer | CFO; Chief Financial Officer | 60 | 2006–2014 | |
| KOCH KEVIN | Director,Officer; Officer | President & CSO; President, CSO | 17 | 2006–2013 | |
| LEFKOFF KYLE | Director | 30 | 2006–2019 | ||
| MOORE JOHN R | Officer | VP, General Counsel | 33 | 2006–2017 | |
| CONWAY ROBERT | Director,Officer | CEO | 18 | 2006–2011 | |
| SNITMAN DAVID | Director,Officer; Officer | COO and VP, Bus Development; COO and VP, Business Devel. | 20 | 2006–2015 | |
| VAN LUNSEN GIL J | Director | 26 | 2006–2019 | ||
| Yates John | Officer | CMO | 2 | 2007 | |
| BULLOCK FRANCIS J | Director | 6 | 2007–2011 | ||
| CARUTHERS MARVIN H | Director | 9 | 2007–2011 | ||
| WILLIAMS DOUGLAS E | Director | 5 | 2007–2010 | ||
| ZABRISKIE JOHN L | Director | 8 | 2007–2013 | ||
| BIOTECHNOLOGY VALUE FUND II LP | Other | 5 | 2011–2014 | ||
| BIOTECHNOLOGY VALUE FUND L P | Other | 5 | 2011–2014 | ||
| BVF INC/IL | Other; TenPercentOwner | 5 | 2011–2014 | ||
| BVF INVESTMENTS LLC | Other | 5 | 2011–2014 | ||
| BVF PARTNERS L P/IL | Other; TenPercentOwner | 5 | 2011–2014 | ||
| LAMPERT MARK N | Other; TenPercentOwner | 5 | 2011–2014 | ||
| Fyfe Gwen A. | Director | 10 | 2012–2019 | ||
| Ratcliffe Liam | Director | 6 | 2012–2013 | ||
| Squarer Ron | Director,Officer | CEO; Chief Executive Officer | 20 | 2012–2019 | |
| Orwin John A | Director | 8 | 2012–2019 | ||
| Needle Michael N | Officer | CMO | 3 | 2013–2014 | |
| Robbins Andrew R | Officer | COO; SVP, Commercial Operations | 16 | 2013–2019 | |
| BAUM CHARLES M | Director | 11 | 2014–2019 | ||
| Saccomano Nicholas A | Officer | CSO | 16 | 2014–2019 | |
| Sandor Victor | Officer | Chief Medical Officer; Chief Medical Officer. | 25 | 2014–2019 | |
| Horin David J | Officer | Interim CFO | 1 | 2015 | |
| Green Jeremy | TenPercentOwner | 12 | 2015–2016 | ||
| Redmile Group, LLC | TenPercentOwner | 12 | 2015–2016 | ||
| Henahan Mary P. | Officer | Chief Financial Officer | 1 | 2015 | |
| Haddock Jason | Officer | CFO | 10 | 2016–2019 | |
| Sharp Shalini | Director | 4 | 2017–2019 | ||
| Oltmans Curtis Gale | Officer | General Counsel | 9 | 2017–2019 | |
| COX CARRIE SMITH | Director | 6 | 2018–2019 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Array BioPharma Inc. | CO | State business registries | name and state |
| Business registration | Array BioPharma Inc. | CO | State business registries | name and state |
| Business registration | ARRAY BIOPHARMA Inc. | CO | State business registries | name and state |
| Business registration | ARRAY BIOPHARMA INC. | CO | State business registries | EIN (EXACT, as the state registration reports it) |
| Business registration | ARRAY BIOPHARMA INC. | CO | State business registries | name and state |
| Business registration | ARRAY BIOPHARMA INC. | CO | State business registries | name and state |
| Business registration | ARRAY BIOPHARMA INC. | CO | State business registries | name and state |
| Business registration | ARRAY BIOPHARMA INC. | CO | State business registries | name and state |
| Business registration | ARRAY BIOPHARMA INC. | CO | State business registries | name and state |
| Federal award recipient | ARRAY BIOPHARMA INC | CO | Federal spending (USAspending) | name and state |
| Paying company | ARRAY BIOPHARMA INC | CO | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Array BioPharma, Inc. | CO | Patents (USPTO) | name and state |
| SEC filer | ARRAY BIOPHARMA INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Array Biopharma Inc. | CO | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | ARRAY BIOPHARMA INC. | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.